Wealth Enhancement Advisory Services »

Silverback Therapeutics shares owned by Wealth Enhancement Advisory Services

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Wealth Enhancement Advisory Services from 13F filings

Historical chart of Wealth Enhancement Advisory Services investment in Silverback Therapeutics

Jan 2024Mar 2024May 2024Jul 2024Sep 2024Nov 2024Jan 2025400k600k800k55k60k
Value ($)Share countHistorical SPRY position of Wealth Enhancement Advisory … Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Wealth Enhancement Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Wealth Enhancement Advisory Services

Quarter filed Position value Share count Share price at filing
2024-12-31 $836k 58k 14.50
2024-06-30 $449k 53k 8.51
2024-03-31 $652k 64k 10.22
2023-12-31 $350k 64k 5.48

More positions owned by Wealth Enhancement Advisory Services

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Msci Intl Moment (IMTM)
Alps Etf Tr Smith Core Plus (SMTH)
Amazon (AMZN)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Schwab Strategic Tr Fundamental Intl (FNDF)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Smlc (DWAS)
J P Morgan Exchange Traded F Us Momentum (JMOM)
Invesco Exchange Traded Fd T S&p500 Quality (SPHQ)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
American Centy Etf Tr Us Large Cap Vlu (AVLV)

View all positions for Wealth Enhancement Advisory Services

Top funds holding Silverback Therapeutics

RA Capital Management
Deerfield Management Company
OrbiMed Advisors
BlackRock
Sr One Capital Management
Alliancebernstein
Vanguard Group
State Street Corporation
Franklin Resources
Alyeska Investment Group
Geode Capital Management
Woodline Partners
Nextech Invest
FMR
Citadel Advisors

View all funds holding Silverback Therapeutics